SCHEMBL4601754

SCHEMBL4601754

CCN(CC)c1ccc(OC(N)=O)c(C)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S100B P04271 1/20 0.51
MAPT P10636 12/20 0.46
ALDH1A1 P00352 9/20 0.46
MAPK1 P28482 5/20 0.46
GFER P55789 4/20 0.46
NPSR1 Q6W5P4 4/20 0.46
L3MBTL1 Q9Y468 3/20 0.44
HTT P42858 5/20 0.44
LMNA P02545 4/20 0.44
SMN1; SMN2 Q16637 5/20 0.42
HSD17B10 Q99714 4/20 0.42
ALOX15 P16050 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
CYP2C19 P33261 2/20 0.41
CYP1A2 P05177 1/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
HPGD P15428 4/20 0.41
ATM Q13315 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3226363 0.76 S100B (0.56) S100BMAPTALDH1A1MAPK1GFER
SCHEMBL10871492 0.75 STS (0.56) S100BMAPTALDH1A1MAPK1GFER
SCHEMBL28178459 0.75 CYP1A2 (0.45) MAPTALDH1A1NPSR1L3MBTL1HTT
SCHEMBL29669768 0.74 L3MBTL1 (0.50) MAPTALDH1A1NPSR1L3MBTL1LMNA
SCHEMBL473085 0.74 L3MBTL1 (0.50) MAPTALDH1A1NPSR1L3MBTL1LMNA
Acetamide SCHEMBL10826862 0.74 S100B (0.80) S100BMAPTALDH1A1MAPK1GFER
SCHEMBL9641577 0.74 STS (0.55) S100BMAPTALDH1A1MAPK1GFER
SCHEMBL12288715 0.73 ACHE (0.51) S100BMAPTALDH1A1MAPK1GFER
SCHEMBL2191597 0.73 PDE10A (0.45) MAPTALDH1A1L3MBTL1LMNASMN1; SMN2
SCHEMBL9684802 0.71 S100B (0.55) S100BMAPTALDH1A1MAPK1GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912645-A2 THERAPEUTIC AGENT FOR DIABETES Takeda Pharmaceutical Company Limited (JP) 2008-04-23 EP claimed
WO-2007018314-A2 THERAPEUTIC AGENT FOR DIABETES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-02-15 WO claimed
EP-1912645-A2 THERAPEUTIC AGENT FOR DIABETES Takeda Pharmaceutical Company Limited (JP) 2008-04-23 EP disclosed
WO-2007018314-A2 THERAPEUTIC AGENT FOR DIABETES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-02-15 WO disclosed